What is the recommended starting dose of Novomix (Biphasic insulin aspart) for an 86kg patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Novomix Dosage for an 86kg Patient

For an 86kg patient starting Novomix (biphasic insulin aspart), initiate at 0.1-0.2 units/kg/day, which translates to 9-17 units daily, typically divided as two-thirds (6-11 units) in the morning and one-third (3-6 units) in the evening. 1, 2

Initial Dosing Calculation

  • Start with 10 units once daily or use weight-based dosing of 0.1-0.2 units/kg/day for insulin-naive patients with type 2 diabetes. 1, 3, 2

  • For this 86kg patient, the calculation yields:

    • Lower range: 86kg × 0.1 = 8.6 units (round to 9 units)
    • Upper range: 86kg × 0.2 = 17.2 units (round to 17 units) 3, 2
  • When using premixed insulin like Novomix, divide the total daily dose as approximately two-thirds before breakfast and one-third before dinner. 2

  • For severe hyperglycemia (HbA1c ≥9%, blood glucose ≥300-350 mg/dL), consider higher starting doses of 0.3-0.5 units/kg/day (26-43 units for this patient). 1, 3, 2

Titration Protocol

  • Increase the dose by 2 units every 3 days if fasting glucose is 140-179 mg/dL, or by 4 units every 3 days if fasting glucose is ≥180 mg/dL. 3, 2

  • Target fasting plasma glucose of 80-130 mg/dL (4.4-7.2 mmol/L). 3, 2

  • If hypoglycemia occurs without clear cause, reduce the dose by 10-20% immediately. 3, 2

  • Daily fasting blood glucose monitoring is essential during the titration phase. 3, 2

Foundation Therapy Considerations

  • Continue metformin (unless contraindicated) when initiating or intensifying insulin therapy, as it reduces total insulin requirements and provides complementary glucose-lowering effects. 3, 2

  • Metformin should be dosed at least 1000mg twice daily (2000mg total) for optimal effect, with a maximum effective dose of up to 2500mg/day. 3

Important Clinical Considerations

  • Novomix should be administered immediately before meals (0-15 minutes), not 30 minutes before like regular human insulin. 4, 5

  • The biphasic formulation contains both rapid-acting and intermediate-acting insulin components, providing both prandial and basal coverage. 4

  • Premixed insulins like Novomix have suboptimal pharmacodynamic profiles for covering postprandial glucose excursions compared to basal-bolus regimens. 1

Critical Pitfalls to Avoid

  • Do not delay insulin therapy in patients not achieving glycemic goals with oral medications alone. 1, 3

  • Avoid using premixed insulins in hospitalized patients due to unacceptably high rates of iatrogenic hypoglycemia. 3, 2

  • When basal insulin exceeds 0.5 units/kg/day (43 units for this patient) without achieving targets, consider transitioning to a basal-bolus regimen rather than continuing to escalate the premixed insulin. 3

  • Never convert from NPH to Novomix on a 1:1 basis—always use 80% of the NPH dose to prevent hypoglycemia. 2

Patient Education Requirements

  • Teach proper insulin injection technique and site rotation to prevent lipohypertrophy. 3

  • Educate on recognition and treatment of hypoglycemia, including having glucose tablets or fast-acting carbohydrates readily available. 3

  • Instruct on self-monitoring of blood glucose, "sick day" management rules, and proper insulin storage. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Initiation and Titration Guidelines for Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.

Expert opinion on pharmacotherapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.